Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology – assisted reproduction technology

References

• van Loendersloot LL, van Wely M, Limpens J, et al. Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis. Hum Reprod Update 2010;16:577–89
   PubMed Web of Science ®Google Scholar
• Rienzi L, Vajta G, Ubaldi F. Predictive value of oocyte morphology in human IVF: a systematic review of the literature. Hum Reprod Update 2010;17:34–45
   PubMedGoogle Scholar
• Revelli A, Delle Piane L, Casano S, et al. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol 2009;7:40
   PubMed Web of Science ®Google Scholar
• Chiu TT, Rogers MS, Law EL, et al. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod 2002;17:1591–6
   PubMed Web of Science ®Google Scholar
• Pal L, Jindal S, Witt BR, Santoro N. Less is more… Increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth following IVF. Fertil Steril 2008;89:1694–701
   PubMed Web of Science ®Google Scholar
• Ciotta L, Stracquadanio M, Pagano I, et al. Effects of myo-inositol supplementation on oocyte’s quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci 2011;15:509–14
   PubMed Web of Science ®Google Scholar
• Papaleo E, Unfer V, Baillargeon JP, et al. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril 2009;91:1750–4
   PubMed Web of Science ®Google Scholar
• Unfer V, Raffone E, Rizzo P, Buffo S. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecol Endocrinol 2011;27:857–61
   PubMed Web of Science ®Google Scholar
• Unfer V, Carlomagno G, Rizzo P, et al. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Eur Rev Med Pharmacol Sci 2011;15:452–7
   PubMed Web of Science ®Google Scholar
• Colazingari S, Treglia M, Najjar R, Bevilacqua A. The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial. Arch Gynecol Obstet 2013;288:1405–11
   PubMed Web of Science ®Google Scholar
• Lisi F, Carfagna P, Oliva MM, et al. Pretreatment with myo-inositol in non-polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reprod Biol Endocrinol 2012;10:52
   PubMed Web of Science ®Google Scholar
• Rizzo P, Raffone E, Benedetto V. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. Eur Rev Med Pharmacol Sci 2010;14:555–61
   PubMed Web of Science ®Google Scholar
• Chattopadhayay R, Ganesh A, Samanta J, et al. Effect of follicular fluid oxidative stress on meiotic spindle formation in infertile women with polycystic ovarian syndrome. Gynecol Obstet Invest 2010;69:197–202
   PubMed Web of Science ®Google Scholar
• Berker B, Kaya C, Aytac R, Satiroglu H. Homocysteine concentrations in follicular fluid are associated with poor oocyte and embryo qualities in polycystic ovary syndrome patients undergoing assisted reproduction. Hum Reprod 2009;24:2293–302
   PubMed Web of Science ®Google Scholar
• Condorelli RA, La Vignera S, Bellanca S, et al. Myoinositol: does it improve sperm mitochondrial function and sperm motility? Urology 2012;79:1290–5
   PubMed Web of Science ®Google Scholar
• Chiu TT, Rogers MS, Briton-Jones C, Haines C. Effects of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes. Hum Reprod 2003;18:408–16
   PubMed Web of Science ®Google Scholar
• Holm P, Booth PJ, Schmidt MH, et al. High bovine blastocyst development in a static in vitro production system using SOFaa medium supplemented with sodium citrate and myo-inositol with or without serum-proteins. Theriogenology 1999;52:683–700
   PubMed Web of Science ®Google Scholar
• Warner SM, Conlon FV, Kane MT. Inositol transport in preimplantation rabbit embryos: effects of embryo stage, sodium, osmolality and metabolic inhibitors. Reproduction 2003;125:479–93. Erratum in: Reproduction 2005;129:128
   PubMed Web of Science ®Google Scholar
• Colazingari S, Fiorenza MT, Carlomagno G, et al. Improvement of mouse embryo quality by myo-inositol supplementation of IVF media. J Assist Reprod Genet 2014;31:463–9
   PubMed Web of Science ®Google Scholar
• Huang LC, Fonteles MC, Houston DB, et al. Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo. Endocrinology 1993;132:652–7
   PubMed Web of Science ®Google Scholar
• Sun TH, Heimark DB, Nguygen T, et al. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. Biochem Biophys Res Commun 2002;293:1092–8
   PubMed Web of Science ®Google Scholar
• Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006;443:651–7
   PubMed Web of Science ®Google Scholar
• Downes CP. The cellular functions of myo-inositol. Biochem Soc Trans 1989;17:259–68
   PubMed Web of Science ®Google Scholar
• Downes CP, Macphee CH. myo-inositol metabolites as cellular signals. Eur J Biochem 1990;193:1–18
   PubMedGoogle Scholar
• Beemster P, Groenen P, Steegers-Theunissen R. Involvement of inositol in reproduction. Nutr Rev 2002;60:80–7
   PubMed Web of Science ®Google Scholar
• Quirk Jr JG, Bleasdale JE. Myo-inositol homeostasis in the human fetus. Obstet Gynecol 1983;62:41–4
   PubMed Web of Science ®Google Scholar
• Greene NDE, Copp AJ. Inositol prevents folate resistant neural tube defects in the mouse. Nat Med 1997;3:60–6
   PubMed Web of Science ®Google Scholar
• Cavalli P, Copp AJ. Inositol and folate resistant neural tube defects. J Med Genet 2002;39:E5
   PubMedGoogle Scholar
• Lewin LM, Yannai Y, Melmed S, Weiss M. Myo-inositol in the reproductive tract of the female rat. Int J Biochem 1982;14:147–50
   PubMedGoogle Scholar
• Chiu TT, Tam PP. A correlation of the outcome of clinical in vitro fertilization with the inositol content and embryotrophic properties of human serum. J Assist Reprod Genet 1992;9:524–30
   PubMed Web of Science ®Google Scholar
• Zacche MM, Caputo L, Filippis S, et al. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome. Gynecol Endocrinol 2009;25:508–13
   PubMed Web of Science ®Google Scholar
• Matsuda M, Tsutsumi K, Kanematsu T, et al. Involvement of phospholipase C-related inactive protein in the mouse reproductive system through the regulation of gonadotropin levels. Biol Reprod 2009;81:681–9
   PubMed Web of Science ®Google Scholar
• Goud PT, Goud AP, Van Oostveldt P, Dhont M. Presence and dynamic redistribution of type I inositol 1,4,5-trisphosphate receptors in human oocytes and embryos during in-vitro maturation, fertilization and early cleavage divisions. Mol Hum Reprod 1999;5:441–51
   PubMed Web of Science ®Google Scholar
• Lowther KM, Weitzman VN, Maier D, Mehlmann LM. Maturation, fertilization, and the structure and function of the endoplasmic reticulum in cryopreserved mouse oocytes. Biol Reprod 2009;81:147–54
   PubMed Web of Science ®Google Scholar
• Kwon HM, Yamauchi A, Uchida S, et al. Cloning of the cDNA for a Na+/myo-inositol cotransporter, a hypertonicity stress protein. J Biol Chem 1992;267:6297–301
   PubMed Web of Science ®Google Scholar
• Higgins BD, Kane MT. Inositol transport in mouse oocytes and preimplantation embryos: effects of mouse strain, embryo stage, sodium and the hexose transport inhibitor, phloridzin. Reproduction 2003;125:111–18
   PubMed Web of Science ®Google Scholar
• Kane MT, Norris M, Harrison RAP. Uptake and incorporation of inositol by preimplantation mouse embryos. J Reprod Fertil 1992;96:617–25
   PubMedGoogle Scholar
• Ajduk A, Ciemerych MA, Nixon V, et al. Fertilization differently affects the levels of cyclin B1 and M-phase promoting factor activity in maturing and metaphase II mouse oocytes. Reproduction 2008;136:741–52
   PubMedGoogle Scholar
• Stachecki JJ, Armant DR. Transient release of calcium from inositol 1,4,5-trisphosphate-specific stores regulates mouse preimplantation development. Development 1996;122:2485–96
   PubMed Web of Science ®Google Scholar
• Homburg R. Polycystic ovary syndrome – from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod 1996;11:29–39
   PubMed Web of Science ®Google Scholar
• Ciampelli M, Fulghesu AM, Cucinelli F, et al. Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. Metabolism 1999;48:167–72
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Battaglia C, Malavasi B, et al. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome. Fertil Steril 2004;81:114–9
   PubMed Web of Science ®Google Scholar
• Nestler JE, Strauss JF 3rd. Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinol Metab Clin North Am 1991;20:807–23
   PubMed Web of Science ®Google Scholar
• Marshall JC, Dunaif A. Should all women with PCOS be treated for insulin resistance? Fertil Steril 2012;97:18–22
   PubMed Web of Science ®Google Scholar
• Costantino D, Minozzi G, Minozzi E, Guaraldi C. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur Rev Med Pharmacol Sci 2009;13:105–10
   PubMed Web of Science ®Google Scholar
• Papaleo E, Unfer V, Baillargeon JP, et al. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol 2007;23:700–3
   PubMed Web of Science ®Google Scholar
• Gerli S, Papaleo E, Ferrari A, Di Renzo GC. Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. Eur Rev Med Pharmacol Sci 2007;11:347–54
   PubMed Web of Science ®Google Scholar
• Nestler JE, Jakubowicz DJ, Reamer P, et al. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med 1999;340:1314–20
   PubMed Web of Science ®Google Scholar
• Iuorno MJ, Jacubowicz DJ, Baillargeon JP, et al. Effect of D-chiro-inositol in lean women with the polycystic ovary syndrome. Endocr Pract 2002;8:417–23
   PubMedGoogle Scholar
• Minozzi M, Costantino D, Guaraldi C, Unfer V. The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome. Gynecol Endocrinol 2011;27:920–4
   PubMed Web of Science ®Google Scholar
• Unfer V, Carlomagno G, Papaleo E, et al. Hyperinsulinemia alters myoinositol to D-chiroinositol ratio in the follicular fluid of patients with PCOS. Reprod Sci 2014;21:854--8. [Epub ahead of print]. PubMed PMID:24501149
   Google Scholar
• Eisenberg F Jr, Bolden AH. Reproductive tract as site of synthesis and secretion of inositol in the male rat. Nature 1964;202:599–600
   PubMed Web of Science ®Google Scholar
• Chauvin TR, Griswold MD. Characterization of the expression and regulation of genes necessary for myo-inositol biosynthesis and transport in the seminiferous epithelium. Biol Reprod 2004;70:744–51
   PubMed Web of Science ®Google Scholar
• Hinton BT, White RW, Setchell BP. Concentrations of myo-inositol in the luminal fluid of the mammalian testis and epididymis. J Reprod Fertil 1980;58:395–9
   PubMedGoogle Scholar
• Cryns K, Shamir A, Van Acker N, et al. IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity. Neuropsychopharmacol 2008;33:674–84
   PubMed Web of Science ®Google Scholar
• Martinez-Heredia J, de Mateo S, Vidal-Taboada JM, et al. Identification of proteomic differences in asthenozoospermic sperm samples. Hum Reprod 2008;23:783–91
   PubMed Web of Science ®Google Scholar
• Colone M, Marelli G, Unfer V, et al. Inositol activity in oligoasthenoteratospermia – an in vitro study. Eur Rev Med Pharmacol Sci 2010;14:891–6
   PubMed Web of Science ®Google Scholar
• Condorelli RA, La Vignera S, Di Bari F, et al. Effects of myoinositol on sperm mitochondrial function in-vitro. Eur Rev Med Pharmacol Sci 2011;15:129–34
   PubMed Web of Science ®Google Scholar
• Marchetti C, Jouy N, Leroy-Martin B, et al. Comparison of four fluorochromes for the detection of the inner mitochondrial membrane potential in human spermatozoa and their correlation with sperm motility. Hum Reprod 2004;19:2267–76
   PubMed Web of Science ®Google Scholar
• Marchetti P, Ballot C, Jouy N, et al. Influence of mitochondrial membrane potential of spermatozoa on in vitro fertilisation outcome. Andrologia 2012;44:136–41
   PubMed Web of Science ®Google Scholar
• Isabella R, Raffone E. Does ovary need D-chiro-inositol? J Ovarian Res 2012;5:14
   PubMed Web of Science ®Google Scholar
• Cheang KI, Baillargeon JP, Essah PA, et al. Insulin-stimulated release of D-chiro-inositol-containing inositol phosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. Metabolism 2008;57:1390–7
   PubMed Web of Science ®Google Scholar
• Larner J. D-chiro-inositol – its functional role in insulin action and its deficit in insulin resistance. Int J Exp Diabetes Res 2002;3:47–60
   PubMedGoogle Scholar
• Ma X, Fan L, Meng Y, et al. Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome. Mol Hum Reprod 2007;13:527–35
   PubMed Web of Science ®Google Scholar
• Arya BK, Haq AU, Chaudhury K. Oocyte quality reflected by follicular fluid analysis in poly cystic ovary syndrome (PCOS): a hypothesis based on intermediates of energy metabolism. Med Hypotheses 2012;78:475–8
   PubMed Web of Science ®Google Scholar
• Carlomagno G, Unfer V, Roseff S. The D-chiro-inositol paradox in the ovary. Fertil Steril 2011;95:2515–6
   PubMed Web of Science ®Google Scholar
• Nordio M, Proietti E. The combined therapy with myo-inositol and D-Chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. Eur Rev Med Pharmacol Sci 2012;16:575–81
   PubMed Web of Science ®Google Scholar
• Larner J, Huang LC, Tang G, et al. Insulin mediators: structure and formation. Cold Spring Harb Symp Quant Biol 1988;53:965–71
   PubMedGoogle Scholar
• Majumder AL, Biswas BB. Biology of inositols and phoshoinositides. Subcellular Biochemistry. The Netherlands; Springer; 2006:2039
   Google Scholar
• Chaudhary K, Babu KN, Joshi VN, et al. NMR-based metabolomics reveals differently expressed metabolites in follicular fluid of PCOS women: potential biomarkers for good quality oocyte? Hum Reprod 2011;26:i226–46
   Google Scholar
• Heimark D1, McAllister J, Larner J. Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls. Endocr J 2014;61:111–17
   PubMed Web of Science ®Google Scholar